Visit our Covid 19 and Preeclampsia resource page. Click Here

2015 Research Funding Available for Preeclampsia and Related Pregnancy Disorders

Preeclampsia Foundation’s research investment catalyzes new approaches to life-threatening complication of pregnancy

Melbourne, Florida – April 16, 2015 – The Preeclampsia Foundation announced that applications are now being accepted for its 2015 Vision Grant program. Up to two medical research Vision Grants will be awarded to study preeclampsia and related hypertensive disorders of pregnancy, up to $20,000 each.

Vision Grants are intended to provide initial funding for novel, innovative research by promising young investigators that will advance progress towards detection, prevention or treatment of preeclampsia, HELLP syndrome and other hypertensive disorders of pregnancy. Post-doctoral, Clinical Fellows or Early Stage Investigators only are eligible to apply. Projects with potential to alter clinical management and improve patient outcomes will receive priority but any well-considered research proposal will be accepted for review. International applications are welcomed; however, submissions must be in English.

The application deadline is June 17, 2015, with award notification September 4, 2015.  More information and instructions for application can be found at

Since its inception, the Preeclampsia Foundation’s Vision Grant program has invested more than $550,000 in novel research – ranging from molecular biology and immunology, to potential therapies, with the goal of supporting new, potentially ground-breaking concepts. These results have, in turn, generated additional funding from the National Institutes of Health, earned scientific presentations at major conferences, and inspired young investigators to challenge a medical conundrum that has baffled the medical community for over 2,400 years.

“I’m impressed by the breadth and quality of applications we receive,” remarked Dr. Thomas Easterling, director of the Preeclampsia Foundation’s Medical Advisory Board. “Our interest is in funding creative, potentially risky, concepts, but without any other source of funding to break out of the usual research pathways currently in play. Vision Grants provide those young investigators the resources they need to seed their ideas, experiment with some off-the-the-beaten track but still well-grounded concepts, and then – if successful – go on to secure more substantial funding for advanced research.”

About the Vision Grant Award Program:  According to the World Health Organization, preeclampsia is one of the least funded areas of research, especially when considered against Disability Adjusted Life Years (DALYs). The Preeclampsia Foundation’s Vision Grants fund medical research pertaining to the pathophysiology, diagnosis, and treatment of hypertensive disorders of pregnancy.

About Preeclampsia:  Preeclampsia is a disorder that occurs during pregnancy and the immediate postpartum period, and affects both the mother and the fetus. It is a rapidly progressive condition characterized by elevated blood pressure and protein in the urine; other symptoms may include swelling in the hands and face, headaches, and visual disturbances. Preeclampsia affects the mother's kidneys, liver and other vital organs and, if undetected or untreated, can lead to seizures (eclampsia), cerebral hemorrhage, failure in vital organs and death. The cause of preeclampsia is still not fully understood, and the only cure for the condition begins with delivery. Approximately five to eight percent of pregnancies are affected by preeclampsia, which, in the United States, translates to approximately 300,000 pregnancies. It is a leading cause of preterm birth, and is responsible for approximately 76,000 maternal deaths and half a million infant deaths worldwide annually. There are several types of preeclampsia, including HELLP syndrome, a particularly dangerous variant.

About the Preeclampsia Foundation:  The Preeclampsia Foundation is a U.S.-based 501(c)(3) non-profit organization established in 2000. It is dedicated to providing patient support and education, raising public awareness, catalyzing research and improving health care practices, envisioning a world where preeclampsia and related hypertensive disorders of pregnancy no longer threaten the lives of mothers and babies. For more information, visit

Related Articles